ArticleJournal for immunotherapy of cancer2020

Autoimmunity linked protein phosphatase PTPN22 as a target for cancer immunotherapy.

Rafael Cubas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.